Page last updated: 2024-11-06

mitomycin and Obstructive Lung Diseases

mitomycin has been researched along with Obstructive Lung Diseases in 2 studies

Mitomycin: An antineoplastic antibiotic produced by Streptomyces caespitosus. It is one of the bi- or tri-functional ALKYLATING AGENTS causing cross-linking of DNA and inhibition of DNA synthesis.
mitomycin : A family of aziridine-containing natural products isolated from Streptomyces caespitosus or Streptomyces lavendulae.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cunningham, D1
Henderson, A1
Soukop, M1
Luedke, D1
McLaughlin, TT1
Daughaday, C1
Luedke, S1
Harrison, B1
Reed, G1
Martello, O1

Other Studies

2 other studies available for mitomycin and Obstructive Lung Diseases

ArticleYear
Chemotherapy improves pulmonary function in a patient with gastric cancer.
    The British journal of clinical practice, 1986, Volume: 40, Issue:6

    Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Doxorubicin; Fluorouracil; Hum

1986
Mitomycin C and vindesine associated pulmonary toxicity with variable clinical expression.
    Cancer, 1985, Feb-01, Volume: 55, Issue:3

    Topics: Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Bronchogenic

1985